|Title:||Advanced MR imaging of gliomas: An update||Authors:||Kao, H.-W.
|Issue Date:||2013||Journal Volume:||2013||Source:||BioMed Research International||Abstract:||
Recent advances in the treatment of cerebral gliomas have increased the demands on noninvasive neuroimaging for the diagnosis, therapeutic planning, tumor monitoring, and patient outcome prediction. In the meantime, improved magnetic resonance (MR) imaging techniques have shown much potentials in evaluating the key pathological features of the gliomas, including cellularity, invasiveness, mitotic activity, angiogenesis, and necrosis, hence, further shedding light on glioma grading before treatment. In this paper, an update of advanced MR imaging techniques is reviewed, and their potential roles as biomarkers of tumor grading are discussed. ? 2013 Hung-Wen Kao et al.
|DOI:||10.1155/2013/970586||SDG/Keyword:||bevacizumab; gadolinium; Ki 67 antigen; vasculotropin; blood brain barrier; brain biopsy; brain blood volume; cancer recurrence; cancer surgery; cellular distribution; contrast enhancement; diffusion kurtosis imaging; diffusion tensor imaging; diffusion weighted imaging; drug response; fractional anisotropy; functional neuroimaging; glioma; human; labeling index; mitosis; molecular imaging; neovascularization (pathology); neuroimaging; non Gaussian diffusion kurtosis imaging; nuclear magnetic resonance imaging; patient monitoring; proton nuclear magnetic resonance; review; susceptibility weighted imaging; treatment planning; treatment response; tumor invasion; tumor necrosis; brain tumor; glioma; neovascularization (pathology); pathology; vascularization; Brain Neoplasms; glioma; Neovascularization, Pathologic; Brain Neoplasms; Glioma; Humans; Magnetic Resonance Imaging; Mitosis; Neoplasm Invasiveness; Neovascularization, Pathologic; Brain Neoplasms; Glioma; Humans; Magnetic Resonance Imaging; Mitosis; Neoplasm Invasiveness; Neovascularization, Pathologic
|Appears in Collections:||生醫電子與資訊學研究所|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.